These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15705904)

  • 1. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.
    Smith JA; Poteet-Smith CE; Xu Y; Errington TM; Hecht SM; Lannigan DA
    Cancer Res; 2005 Feb; 65(3):1027-34. PubMed ID: 15705904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of rhamnose substituents on the potency of SL0101, an inhibitor of the Ser/Thr kinase, RSK.
    Smith JA; Maloney DJ; Clark DE; Xu Y; Hecht SM; Lannigan DA
    Bioorg Med Chem; 2006 Sep; 14(17):6034-42. PubMed ID: 16723233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the activity of the RSK-specific inhibitor, SL0101.
    Smith JA; Maloney DJ; Hecht SM; Lannigan DA
    Bioorg Med Chem; 2007 Jul; 15(14):5018-34. PubMed ID: 17512736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.
    Clark DE; Errington TM; Smith JA; Frierson HF; Weber MJ; Lannigan DA
    Cancer Res; 2005 Apr; 65(8):3108-16. PubMed ID: 15833840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
    Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
    Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a potent and selective inhibitor of p90 Rsk.
    Maloney DJ; Hecht SM
    Org Lett; 2005 Mar; 7(6):1097-9. PubMed ID: 15760148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancers.
    Aronchik I; Appleton BA; Basham SE; Crawford K; Del Rosario M; Doyle LV; Estacio WF; Lan J; Lindvall MK; Luu CA; Ornelas E; Venetsanakos E; Shafer CM; Jefferson AB
    Mol Cancer Res; 2014 May; 12(5):803-12. PubMed ID: 24554780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
    Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
    Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytes.
    Stathopoulou K; Schobesberger S; Bork NI; Sprenger JU; Perera RK; Sotoud H; Geertz B; David JP; Christ T; Nikolaev VO; Cuello F
    Cell Signal; 2019 Nov; 63():109362. PubMed ID: 31344438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three acetylated flavonol glycosides from Forsteronia refracta that specifically inhibit p90 RSK.
    Xu YM; Smith JA; Lannigan DA; Hecht SM
    Bioorg Med Chem; 2006 Jun; 14(11):3974-7. PubMed ID: 16524738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
    Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
    Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.
    Utepbergenov D; Derewenda U; Olekhnovich N; Szukalska G; Banerjee B; Hilinski MK; Lannigan DA; Stukenberg PT; Derewenda ZS
    Biochemistry; 2012 Aug; 51(33):6499-510. PubMed ID: 22846040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paving the way for targeting RSK in cancer.
    Romeo Y; Roux PP
    Expert Opin Ther Targets; 2011 Jan; 15(1):5-9. PubMed ID: 20958120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1.
    Neise D; Sohn D; Stefanski A; Goto H; Inagaki M; Wesselborg S; Budach W; Stühler K; Jänicke RU
    Cell Death Dis; 2013 Oct; 4(10):e859. PubMed ID: 24136223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Implications of RSK1-3 in Human Breast Cancer.
    Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RSK family of kinases: emerging roles in cellular signalling.
    Anjum R; Blenis J
    Nat Rev Mol Cell Biol; 2008 Oct; 9(10):747-58. PubMed ID: 18813292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regioselective Synthesis of a
    Li Y; Sandusky ZM; Vemula R; Zhang Q; Wu B; Fukuda S; Li M; Lannigan DA; O'Doherty GA
    Org Lett; 2020 Feb; 22(4):1448-1452. PubMed ID: 32009414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability.
    Hilinski MK; Mrozowski RM; Clark DE; Lannigan DA
    Bioorg Med Chem Lett; 2012 May; 22(9):3244-7. PubMed ID: 22464132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MAP kinase ERK5 binds to and phosphorylates p90 RSK.
    Ranganathan A; Pearson GW; Chrestensen CA; Sturgill TW; Cobb MH
    Arch Biochem Biophys; 2006 May; 449(1-2):8-16. PubMed ID: 16626623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and function of the RSK family of protein kinases.
    Romeo Y; Zhang X; Roux PP
    Biochem J; 2012 Jan; 441(2):553-69. PubMed ID: 22187936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.